Scarica l'app Stockscreener
69.45
1.77%
-1.25
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PTCT Giù?
Forum
Previsione
Ptc Therapeutics Inc Borsa (PTCT) Ultime notizie
Will PTC Therapeutics Inc. benefit from current market trendsMarket Movement Recap & Short-Term High Return Ideas - mfd.ru
PTC Withdraws Translarna US FDA Filing - Citeline News & Insights
PTC Therapeutics Ends Bid to Seek FDA Approval for Rare Muscle Disease Drug - MedCity News
PTC Withdraws FDA Filing For Translarna - Citeline News & Insights
PTC Therapeutics withdraws Translarna NDA - The Pharma Letter
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak Proof - Benzinga
PTC Therapeutics Withdraws NDA Resubmission for Translarna Following FDA Feedback - marketscreener.com
PTC Therapeutics Withdraws Translarna NDA After FDA Feedback - TipRanks
PTC Therapeutics falls after withdrawing muscle disorder drug marketing application - TradingView
PTC Therapeutics stock falls after withdrawing Translarna drug application By Investing.com - Investing.com Canada
PTC Therapeutics Provides Regulatory Update on Translarna™ - Yahoo Finance
PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Finviz
PTC Therapeutics (PTCT) Projected to Post Quarterly Earnings on Thursday - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) Shareholders Have Earned a 18% CAGR Over the Last Three Years - 富途牛牛
PTC Therapeutics, Inc. (PTCT) Launches SUFIANCE for PKU - MSN
Price Action: How does Guardian Pharmacy Services Inc correlate with NasdaqTrade Risk Assessment & Safe Entry Point Alerts - baoquankhu1.vn
PTC Therapeutics Inc (NASDAQ:PTCT): A GARP Stock with Strong Growth and Moderate Valuation - ChartMill
PTC Therapeutics, Inc. $PTCT Stock Position Decreased by BI Asset Management Fondsmaeglerselskab A S - MarketBeat
Johnson & Johnson vs PTC Therapeutics: Which Stock Could Rally? - Trefis
PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 - Finviz
Between PTC Therapeutics and Eli Lilly, Which Stock Looks Set to Break Out? - Trefis
PTC Therapeutics vs Merck: Which Is the Stronger Buy Today? - Trefis
Understanding Momentum Shifts in (PTCT) - Stock Traders Daily
Tech Rally: Is PTC Therapeutics Inc a stock for growth or value investorsJuly 2025 EndofMonth & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
WCM Investment Management LLC Acquires Shares of 147,065 PTC Therapeutics, Inc. $PTCT - MarketBeat
PTC Therapeutics (PTCT) Investor Outlook: An 18% Upside Potential Amidst Robust Pipeline - DirectorsTalk Interviews
PTCT SEC FilingsPtc Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
PTC Therapeutics Inc (NASDAQ:PTCT) Combines High-Growth Momentum with Bullish Technical Setup - ChartMill
PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Meme Stocks: What is PTC Therapeutics Inc.’s book value per shareEarnings Overview Summary & Growth Focused Entry Reports - baoquankhu1.vn
Evaluating PTC Therapeutics (PTCT) Valuation After Barclays Rating Upgrade And Growing Analyst Confidence - Yahoo Finance
Converging Analyst Upgrades on PTC’s Rare Disease Pipeline Might Change The Case For Investing In PTC Therapeutics (PTCT) - Sahm
Barclays Upgrades PTC Therapeutics (PTCT) - Nasdaq
PTC Therapeutics (PTCT) Sees Analyst Rating Upgrade to Overweigh - GuruFocus
PTC Therapeutics stock initiated with Overweight rating at Barclays By Investing.com - Investing.com Canada
PTC Therapeutics, Inc. (PTCT) Stock Analysis: Potential Upside with Innovative Rare Disorder Treatments - DirectorsTalk Interviews
A Look At PTC Therapeutics (PTCT) Valuation After New 2026 Revenue Guidance And Morgan Stanley Support - Sahm
Sector Gamma AS Increases Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Avoiding Lag: Real-Time Signals in (PTCT) Movement - Stock Traders Daily
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Morgan Stanley Is Bullish on PTC Therapeutics, Inc. (PTCT) as Small-Cap Biotech Outlook Improves - Finviz
QRG Capital Management Inc. Takes Position in PTC Therapeutics, Inc. $PTCT - MarketBeat
Momentum Shift: What is International Money Express Incs market positionTrade Exit Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn
First Week of September 18th Options Trading For PTC Therapeutics - Nasdaq
Does 2026 Revenue Guidance And Sephience Momentum Change The Bull Case For PTC Therapeutics (PTCT)? - Sahm
Discipline and Rules-Based Execution in PTCT Response - Stock Traders Daily
PTC Therapeutics projects FY26 product revenue between $700M to $800M - MSN
PTC Therapeutics reports $92.5M in Q4 Sephience revenue By Investing.com - Investing.com Nigeria
Lobbying Update: $50,000 of PTC THERAPEUTICS INC. lobbying was just disclosed - Quiver Quantitative
Ptc Therapeutics CEO Klein sells $192k in shares By Investing.com - Investing.com Nigeria
Ptc Therapeutics CEO Klein sells $192k in shares - Investing.com
Utter, SVP at Ptc Therapeutics, sells $79k in shares By Investing.com - Investing.com Canada
Pauwels Eric, chief business officer of Ptc Therapeutics, sells $566k in shares - Investing.com Canada
PTC Therapeutics (NASDAQ:PTCT) VP Sells $180,330.02 in Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 4,602 Shares of Stock - MarketBeat
Insider Selling: PTC Therapeutics (NASDAQ:PTCT) Insider Sells 881 Shares of Stock - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) EVP Lee Scott Golden Sells 866 Shares - MarketBeat
PTC Therapeutics (NASDAQ:PTCT) CEO Sells $192,195.30 in Stock - MarketBeat
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):